id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2026-P-1583-0002,FDA,FDA-2026-P-1583,Acknowledgement Letter from FDA DMB to Jude Fiorini,Other,Acknowledgement Letter/Receipt,2026-02-11T05:00:00Z,2026,2,2026-02-11T05:00:00Z,,2026-02-11T22:59:58Z,,0,0,09000064b91a3763
FDA-2026-P-1583-0007,FDA,FDA-2026-P-1583,Reference 4 - Second edition of guidelines for evaluating the efficacy of anthelmintics for dogs and cats,Supporting & Related Material,Background Material,2026-02-11T05:00:00Z,2026,2,,,2026-02-11T23:00:15Z,,0,0,09000064b91a3353
FDA-2026-P-1583-0004,FDA,FDA-2026-P-1583,Reference 1 - Pathogens in fleas collected from cats and dogs - distribution and prevalence in the UK,Supporting & Related Material,Background Material,2026-02-11T05:00:00Z,2026,2,,,2026-02-11T23:00:06Z,,0,0,09000064b91a3350
FDA-2026-P-1583-0001,FDA,FDA-2026-P-1583,Citizen Petition from Jude Fiorini,Other,Citizen Petition,2026-02-11T05:00:00Z,2026,2,2026-02-11T05:00:00Z,,2026-02-11T22:55:08Z,,1,0,09000064b91a3760
FDA-2026-P-1583-0006,FDA,FDA-2026-P-1583,Reference 3 - Analysis of Dipylidium caninum tapeworms from dogs and cats or their respective fleas,Supporting & Related Material,Background Material,2026-02-11T05:00:00Z,2026,2,,,2026-02-11T23:00:12Z,,0,0,09000064b91a3352
FDA-2026-P-1583-0005,FDA,FDA-2026-P-1583,Reference 2 - Occurence of Dipylidium caninum in fleas from client-owned cats and dogs in Europe using a new PCR detection assay,Supporting & Related Material,Background Material,2026-02-11T05:00:00Z,2026,2,,,2026-02-11T23:00:09Z,,0,0,09000064b91a3351
FDA-2026-P-1583-0003,FDA,FDA-2026-P-1583,Exhibit A - Statement of Grounds,Supporting & Related Material,Background Material,2026-02-11T05:00:00Z,2026,2,,,2026-02-11T23:00:04Z,,0,0,09000064b91a334f